Moderna seeks EU authorization for Covid-19 vaccine in younger children

Moderna Inc on Tuesday sought conditional advertising authorization with the European Medicines Agency to be used of its Covid-19 vaccine in youngsters within the age-group of 6-11 years.
The vaccine was approved to be used in teenagers aged 12 to 17 years by the European Union in July, however a number of international locations together with Sweden have paused its use for folks aged 30 and youthful attributable to uncommon heart-related side-effects.
The drugmaker sought US authorization of its vaccine to be used in teenagers in June and is awaiting a choice by the US Food and Drug Administration.
“This marks our first submission for the use of our vaccine in this age group,” stated Stéphane Bancel, Chief Executive of Moderna, including the corporate will submit the information to different regulatory companies around the globe.